New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.

Abdool Karim, Salim S; de Oliveira, Tulio

Abdool Karim, Salim S; de Oliveira, Tulio.

Abdool Karim SS; Centre for the AIDS Program of Research in South Africa, Durban, South Africa salim.abdoolkarim@caprisa.org.
de Oliveira T; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Durban, South Africa.

N Engl J Med ; 384(19): 1866-1868, 2021 05 13.

Article in English | MEDLINE | ID: covidwho-1147863

Subject(s)

COVID-19 Vaccines/immunology; COVID-19/virology; Immunogenicity, Vaccine; SARS-CoV-2/pathogenicity; Antibodies, Neutralizing/blood; COVID-19/epidemiology; COVID-19/transmission; Humans; Mutation; SARS-CoV-2/genetics; South Africa/epidemiology; Treatment Outcome; United Kingdom/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunogenicity, Vaccine / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Africa / Europa Language: English Journal: N Engl J Med Year: 2021 Document Type: Article Affiliation country: NEJMc2100362

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google